Stay updated on Pembrolizumab Neoadjuvant in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Neoadjuvant in HCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor page update or release; the study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-08-09T11:50:48.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.3 to v3.6.4, signaling a new build was applied to the page.
    Difference
    0.1%
    Check dated 2026-07-26T00:20:40.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a platform update. No study information or content on the page is changed.
    Difference
    0.1%
    Check dated 2026-07-04T13:30:36.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The revision note now shows v3.6.2, replacing the previous v3.6.0. This indicates a new site release/version update rather than a substantive change to page content.
    Difference
    0.1%
    Check dated 2026-06-27T06:21:30.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page lists Masatoshi Kudo as the investigator (without the institution) and introduces Last verified metadata, while adding help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updating the revision from v3.5.5 to v3.6.0.
    Difference
    2%
    Check dated 2026-06-13T00:28:46.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Revision badge updated from v3.5.4 to v3.5.5, representing a minor page update without changes to study content or results.
    Difference
    0.1%
    Check dated 2026-06-05T22:14:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Neoadjuvant in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.